STAGE IIB RECTAL CANCER AJCC V8
Clinical trials for STAGE IIB RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to shrink rectal tumors before surgery
Disease control OngoingThis early-stage study aims to find the safest dose of the chemotherapy drug TAS-102 when given alongside radiation therapy to patients with stage II or III rectal cancer. The goal is to shrink the tumor before the patient undergoes standard surgery and follow-up chemotherapy. Re…
Matched conditions: STAGE IIB RECTAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Tracking life after rectal cancer: how surgery affects daily living
Knowledge-focused TerminatedThis study aims to understand how rectal cancer surgery affects patients' quality of life over time. Researchers will follow 430 patients for up to 5 years after their surgery, asking them to complete questionnaires about their daily experiences. The goal is to gather information…
Matched conditions: STAGE IIB RECTAL CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Cancer's hidden cost: study tracks financial toll on patients
Knowledge-focused OngoingThis study aims to understand how cancer treatment affects patients' finances and employment. Researchers are following 565 people with early-stage colon or rectal cancer for two years, asking them to complete surveys about costs, work life, and quality of life. The goal is to me…
Matched conditions: STAGE IIB RECTAL CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC